India’s leading FMCG company Dabur India is expected to begin FY27 on a positive note, with market experts forecasting double-digit growth in net profit for the first quarter. Strong consumer demand, steady rural recovery, and healthy sales across key product categories are likely to support the company’s financial performance during the April–June quarter. Investors are now eagerly awaiting the official Q1 results to see whether Dabur can maintain its growth momentum despite rising competition and fluctuating raw material prices.
Over the past few quarters, Dabur has focused on expanding its presence in both urban and rural markets while strengthening its portfolio of healthcare, personal care, food, and beverage products. This balanced business strategy is expected to help the company deliver another quarter of stable earnings and improved profitability.
One of the biggest reasons behind the expected profit growth is the continued demand for Dabur’s products across different categories. Consumers have shown consistent interest in daily-use items such as packaged juices, oral care products, hair oils, shampoos, honey, digestive products, and Ayurvedic healthcare solutions.
Market estimates suggest that Dabur could report double-digit growth in net profit for the first quarter of FY27. Along with healthy sales, improved operational efficiency and disciplined cost management are expected to support earnings.
The company has been focusing on optimizing its supply chain, improving manufacturing efficiency, and managing expenses carefully. These initiatives have helped protect profitability even when raw material prices have experienced fluctuations.
If the company successfully maintains healthy operating margins, investors are likely to view the results as another sign of strong business execution.Market estimates suggest that Dabur could report double-digit growth in net profit for the first quarter of FY27. Along with healthy sales, improved operational efficiency and disciplined cost management are expected to support earnings.
The company has been focusing on optimizing its supply chain, improving manufacturing efficiency, and managing expenses carefully. These initiatives have helped protect profitability even when raw material prices have experienced fluctuations.
If the company successfully maintains healthy operating margins, investors are likely to view the results as another sign of strong business execution.
Dabur’s diversified product portfolio remains one of its biggest strengths. The company’s healthcare segment, which includes products such as chyawanprash, honey, digestive solutions, and Ayurvedic medicines, continues to enjoy strong consumer trust.
Similarly, its personal care business—including hair oils, toothpaste, face washes, skin care products, and shampoos—has remained an important contributor to overall sales. Continuous product innovation and strong brand recognition have helped the company compete effectively in the highly competitive FMCG market.
